These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 29153778)
1. The frontline of controlled human malaria infections: A report from the controlled human infection models Workshop in Leiden University Medical Centre 5 May 2016. Roestenberg M; Mordmüller B; Ockenhouse C; Mo A; Yazdanbakhsh M; Kremsner PG Vaccine; 2017 Dec; 35(51):7065-7069. PubMed ID: 29153778 [TBL] [Abstract][Full Text] [Related]
2. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria. Mo AX; Pesce J; Hall BF Vaccine; 2015 Jun; 33(25):2851-7. PubMed ID: 25917675 [TBL] [Abstract][Full Text] [Related]
3. Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers. Tumbo AM; Schindler T; Dangy JP; Orlova-Fink N; Bieri JR; Mpina M; Milando FA; Juma O; Hamad A; Nyakarungu E; Chemba M; Mtoro A; Ramadhan K; Olotu A; Makweba D; Mgaya S; Stuart K; Perreau M; Stapleton JT; Jongo S; Hoffman SL; Tanner M; Abdulla S; Daubenberger C Virol J; 2021 Jan; 18(1):28. PubMed ID: 33499880 [TBL] [Abstract][Full Text] [Related]
4. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Jongo SA; Shekalaghe SA; Church LWP; Ruben AJ; Schindler T; Zenklusen I; Rutishauser T; Rothen J; Tumbo A; Mkindi C; Mpina M; Mtoro AT; Ishizuka AS; Kassim KR; Milando FA; Qassim M; Juma OA; Mwakasungula S; Simon B; James ER; Abebe Y; Kc N; Chakravarty S; Saverino E; Bakari BM; Billingsley PF; Seder RA; Daubenberger C; Sim BKL; Richie TL; Tanner M; Abdulla S; Hoffman SL Am J Trop Med Hyg; 2018 Aug; 99(2):338-349. PubMed ID: 29943719 [TBL] [Abstract][Full Text] [Related]
5. Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya. Hodgson SH; Juma E; Salim A; Magiri C; Njenga D; Molyneux S; Njuguna P; Awuondo K; Lowe B; Billingsley PF; Cole AO; Ogwang C; Osier F; Chilengi R; Hoffman SL; Draper SJ; Ogutu B; Marsh K Malar J; 2015 Apr; 14():182. PubMed ID: 25927522 [TBL] [Abstract][Full Text] [Related]
6. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498 [TBL] [Abstract][Full Text] [Related]
15. Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial. Bastiaens GJH; van Meer MPA; Scholzen A; Obiero JM; Vatanshenassan M; van Grinsven T; Sim BKL; Billingsley PF; James ER; Gunasekera A; Bijker EM; van Gemert GJ; van de Vegte-Bolmer M; Graumans W; Hermsen CC; de Mast Q; van der Ven AJAM; Hoffman SL; Sauerwein RW Am J Trop Med Hyg; 2016 Mar; 94(3):663-673. PubMed ID: 26711509 [TBL] [Abstract][Full Text] [Related]
16. Controlled Human Malaria Infection: Applications, Advances, and Challenges. Stanisic DI; McCarthy JS; Good MF Infect Immun; 2018 Jan; 86(1):. PubMed ID: 28923897 [TBL] [Abstract][Full Text] [Related]